40
InSitu Biologics, Inc. raises $1.3M under Reg D
Company raise · Raising · Offering $2.5M · Sold $1.3M · OAKDALE, MN · filed 2026-08-10
20
InSitu Biologics, Inc. files Form D
Company raise update · Raising · OAKDALE, MN · Form D/A filed 2026-10-14
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Daniel Halpern | Executive Officer, Director |
| Bill Taylor | Executive Officer |
| Sandi Klemann | Executive Officer |
| Robert Wilson | Director |
| Greg Van Guilder | Director |
| Ivan Shaw | Director |
Signed by Daniel Halpern, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
InSitu Biologics, Inc raises $4M under Reg D
Company raise · Raising · Offering $8M · Sold $4M · OAKDALE, MN · filed 2025-12-18